Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Pilcher

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Differences in expression of tumor suppressor, innate immune, inflammasome, and potassium/gap junction channel host genes significantly predict viral reservoir size during treated HIV infectionAshok K Dwivedi, David A Siegel, Cassandra Thanh, et al.
The Journal of Infectious Diseases|February 26, 2015
Longitudinal Genetic Characterization Reveals That Cell Proliferation Maintains a Persistent HIV Type 1 DNA Pool During Effective HIV TherapySusanne von Stockenstrom, Lina Odevall, Eunok Lee, et al.
Nature Communications|November 18, 2024
Rapid biphasic decay of intact and defective HIV DNA reservoir during acute treated HIV diseaseAlton Barbehenn, Lei Shi, Junzhe Shao, et al.
Medrxiv : the Preprint Server for Health Sciences|April 8, 2024
Rapid Biphasic Decay of Intact and Defective HIV DNA Reservoir During Acute Treated HIV DiseaseAlton Barbehenn, Lei Shi, Junzhe Shao, et al.
AIDS (London, England)|January 25, 2023
Host variation in type I interferon signaling genes (MX1), C-C chemokine receptor type 5 gene, and major histocompatibility complex class I alleles in treated HIV+ noncontrollers predict viral reservoir sizeDavid A Siegel, Cassandra Thanh, Eunice Wan, et al.
Plos Pathogens|November 29, 2023
A cohort-based study of host gene expression: tumor suppressor and innate immune/inflammatory pathways associated with the HIV reservoir sizeAshok K Dwivedi, Germán G Gornalusse, David A Siegel, et al.
Plos Pathogens|May 15, 2013
Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patientSteven A Yukl, Eli Boritz, Michael Busch, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Differences in expression of tumor suppressor, innate immune, inflammasome, and potassium/gap junction channel host genes significantly predict viral reservoir size during treated HIV infectionAshok K Dwivedi, David A Siegel, Cassandra Thanh, et al.
The Journal of Infectious Diseases|February 26, 2015
Longitudinal Genetic Characterization Reveals That Cell Proliferation Maintains a Persistent HIV Type 1 DNA Pool During Effective HIV TherapySusanne von Stockenstrom, Lina Odevall, Eunok Lee, et al.
Nature Communications|November 18, 2024
Rapid biphasic decay of intact and defective HIV DNA reservoir during acute treated HIV diseaseAlton Barbehenn, Lei Shi, Junzhe Shao, et al.
Medrxiv : the Preprint Server for Health Sciences|April 8, 2024
Rapid Biphasic Decay of Intact and Defective HIV DNA Reservoir During Acute Treated HIV DiseaseAlton Barbehenn, Lei Shi, Junzhe Shao, et al.
AIDS (London, England)|January 25, 2023
Host variation in type I interferon signaling genes (MX1), C-C chemokine receptor type 5 gene, and major histocompatibility complex class I alleles in treated HIV+ noncontrollers predict viral reservoir sizeDavid A Siegel, Cassandra Thanh, Eunice Wan, et al.
Plos Pathogens|November 29, 2023
A cohort-based study of host gene expression: tumor suppressor and innate immune/inflammatory pathways associated with the HIV reservoir sizeAshok K Dwivedi, Germán G Gornalusse, David A Siegel, et al.
Plos Pathogens|May 15, 2013
Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patientSteven A Yukl, Eli Boritz, Michael Busch, et al.
Pageof 2